Compile Data Set for Download or QSAR
Report error Found 90 Enz. Inhib. hit(s) with all data for entry = 7175
TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179558(US9126980, 3)
Affinity DataIC50: 90.4nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179558(US9126980, 3)
Affinity DataIC50: 127nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179566(US9126980, 11)
Affinity DataIC50: 253nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179580(US9126980, 25)
Affinity DataIC50: 255nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179597(US9126980, 42)
Affinity DataIC50: 255nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179590(US9126980, 35)
Affinity DataIC50: 257nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179593(US9126980, 38)
Affinity DataIC50: 269nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179597(US9126980, 42)
Affinity DataIC50: 270nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179590(US9126980, 35)
Affinity DataIC50: 272nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179600(US9126980, 45)
Affinity DataIC50: 293nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179557(US9126980, 2)
Affinity DataIC50: 295nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179566(US9126980, 11)
Affinity DataIC50: 296nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179583(US9126980, 28)
Affinity DataIC50: 311nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179582(US9126980, 27)
Affinity DataIC50: 315nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179593(US9126980, 38)
Affinity DataIC50: 328nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179581(US9126980, 26)
Affinity DataIC50: 370nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179557(US9126980, 2)
Affinity DataIC50: 377nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179560(US9126980, 5)
Affinity DataIC50: 412nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179580(US9126980, 25)
Affinity DataIC50: 427nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179583(US9126980, 28)
Affinity DataIC50: 448nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179582(US9126980, 27)
Affinity DataIC50: 454nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179573(US9126980, 18)
Affinity DataIC50: 457nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179561(US9126980, 6)
Affinity DataIC50: 465nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179579(US9126980, 24)
Affinity DataIC50: 466nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179562(US9126980, 7)
Affinity DataIC50: 474nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179601(US9126980, 46)
Affinity DataIC50: 475nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179571(US9126980, 16)
Affinity DataIC50: 475nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179600(US9126980, 45)
Affinity DataIC50: 480nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179581(US9126980, 26)
Affinity DataIC50: 494nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179587(US9126980, 32)
Affinity DataIC50: 512nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179556(US9126980, 1)
Affinity DataIC50: 519nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179599(US9126980, 44)
Affinity DataIC50: 522nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179584(US9126980, 29)
Affinity DataIC50: 529nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179596(US9126980, 41)
Affinity DataIC50: 531nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179569(US9126980, 14)
Affinity DataIC50: 559nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179595(US9126980, 40)
Affinity DataIC50: 562nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179561(US9126980, 6)
Affinity DataIC50: 563nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179594(US9126980, 39)
Affinity DataIC50: 566nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179573(US9126980, 18)
Affinity DataIC50: 585nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179560(US9126980, 5)
Affinity DataIC50: 609nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179587(US9126980, 32)
Affinity DataIC50: 631nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179594(US9126980, 39)
Affinity DataIC50: 632nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179562(US9126980, 7)
Affinity DataIC50: 638nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179571(US9126980, 16)
Affinity DataIC50: 640nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179589(US9126980, 34)
Affinity DataIC50: 641nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179579(US9126980, 24)
Affinity DataIC50: 652nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179596(US9126980, 41)
Affinity DataIC50: 660nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179563(US9126980, 8)
Affinity DataIC50: 664nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179601(US9126980, 46)
Affinity DataIC50: 666nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandPNGBDBM179595(US9126980, 40)
Affinity DataIC50: 673nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

Displayed 1 to 50 (of 90 total ) | Next | Last >>
Jump to: